UA96984C2 - Reduction of risk diarrhoea - Google Patents

Reduction of risk diarrhoea

Info

Publication number
UA96984C2
UA96984C2 UAA200910824A UAA200910824A UA96984C2 UA 96984 C2 UA96984 C2 UA 96984C2 UA A200910824 A UAA200910824 A UA A200910824A UA A200910824 A UAA200910824 A UA A200910824A UA 96984 C2 UA96984 C2 UA 96984C2
Authority
UA
Ukraine
Prior art keywords
diarrhoea
risk
reduction
probiotic
longumin
Prior art date
Application number
UAA200910824A
Other languages
English (en)
Inventor
Флорэнс Рошат
Карл-Йозэф Хубэр-Хааг
Мари-Клер Фишот
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Нестек С.А. filed Critical Нестек С.А.
Publication of UA96984C2 publication Critical patent/UA96984C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pediatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Изобретение относится к применению пробиотика Lactobacillus rhamnosus и пробиотика Bifidobacterium longum в производстве лекарственного средства или лекарственной пищевой композиции для продолжительной профилактики диареи у детей грудного и раннего возраста на протяжении по крайней мере первых трех месяцев жизни.
UAA200910824A 2007-03-28 2008-02-20 Reduction of risk diarrhoea UA96984C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07105078A EP1974735A1 (en) 2007-03-28 2007-03-28 Reduction of risk of diarrhoea

Publications (1)

Publication Number Publication Date
UA96984C2 true UA96984C2 (en) 2011-12-26

Family

ID=38314131

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200910824A UA96984C2 (en) 2007-03-28 2008-02-20 Reduction of risk diarrhoea

Country Status (17)

Country Link
US (1) US8562971B2 (ru)
EP (2) EP1974735A1 (ru)
CN (1) CN101641109A (ru)
AU (1) AU2008231930B2 (ru)
BR (1) BRPI0809630A2 (ru)
CA (1) CA2678525A1 (ru)
CL (1) CL2008000927A1 (ru)
ES (1) ES2454243T3 (ru)
MX (1) MX2009009670A (ru)
MY (1) MY150657A (ru)
PL (1) PL2142198T3 (ru)
PT (1) PT2142198E (ru)
RU (1) RU2491080C2 (ru)
TW (1) TW200911278A (ru)
UA (1) UA96984C2 (ru)
WO (1) WO2008116708A1 (ru)
ZA (1) ZA200907539B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2445361C2 (ru) * 2006-06-13 2012-03-20 Нестек С.А. Профилактика и лечение воспаления среднего уха с помощью непатогенных штаммов бактерий
EP2452574A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
WO2010063601A1 (en) * 2008-12-05 2010-06-10 Nestec S.A. Compositions for use in low-birth weight infants
FI121952B (fi) * 2009-05-06 2011-06-30 Oriola Oy Menetelmä pisaroina annosteltavan terveystuotteen valmistamiseksi
EP2289527B1 (en) * 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
EP2308498A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
JP2013543730A (ja) * 2010-11-11 2013-12-09 ネステク ソシエテ アノニム 非複製性プロバイオティクス微生物を含有するスプーナブルヨーグルト調製物
EP2452573A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional composition with animal fats and vegetable fats
EP2452572A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for infants and children
CA2824960A1 (en) * 2011-02-04 2012-08-09 The Regents Of The University Of California Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
JP2014516589A (ja) 2011-06-20 2014-07-17 エイチ．ジェイ．ハインツ カンパニー プロバイオティック組成物及び方法（ｐｒｏｂｉｏｔｉｃｃｏｍｐｏｓｉｔｉｏｎａｎｄｍｅｔｈｏｄｓ）
US20140255365A1 (en) * 2013-03-11 2014-09-11 Mead Johnson Nutrition Company Oral Electrolyte Solution Containing Lactoferrin and Uses Thereof
US20150094266A1 (en) * 2013-06-11 2015-04-02 Novintethical Pharma, SA Xyloglucan and protein compositions for the treatment of intestinal disorders
ITMI20130960A1 (it) * 2013-06-11 2014-12-12 Novintethical Pharma Sagl Composizioni a base di xiloglucano per il trattamento di disturbi gastrointestinali
CA2945631C (en) * 2014-04-15 2023-04-11 Novintethical Pharma Sa Compositions based on xyloglucan and proteins for the treatment of intestinal disorders
ES2965306T3 (es) * 2016-12-16 2024-04-12 Gervais Danone Sa Composición probiótica que comprende cepas de Lactobacillus rhamnosus y Lactobacillus paracasei
CA3088630A1 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
CN110432494A (zh) * 2018-05-03 2019-11-12 广州普维君健药业有限公司 防治婴幼儿过敏性湿疹和/或腹泻的益生菌组合物和应用
WO2020051379A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
AU2022391767A1 (en) 2021-11-22 2024-07-04 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
DK0768375T4 (da) 1992-07-06 2002-09-16 Nestle Sa Mælkesyrebakterier
EP0577903B1 (fr) 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
EP1254075B1 (en) 2000-01-21 2007-02-21 U.S. Borax Inc. Nonaborate compositions and their preparation
US20070031537A1 (en) * 2003-06-23 2007-02-08 Marie-Cristene Secretin Infant or follow-on formula
MX2007012697A (es) * 2005-04-13 2008-01-14 Nestec Sa Formula para infantes con probioticos.
US20070020249A1 (en) * 2005-04-29 2007-01-25 Downs Bernard W Compositions for prevention and treatement of symptoms of gastrointestinal distress

Also Published As

Publication number Publication date
MY150657A (en) 2014-02-14
PL2142198T3 (pl) 2014-07-31
AU2008231930B2 (en) 2014-02-06
TW200911278A (en) 2009-03-16
WO2008116708A1 (en) 2008-10-02
US20100129335A1 (en) 2010-05-27
RU2491080C2 (ru) 2013-08-27
US8562971B2 (en) 2013-10-22
PT2142198E (pt) 2014-04-02
CN101641109A (zh) 2010-02-03
EP2142198A1 (en) 2010-01-13
ES2454243T3 (es) 2014-04-10
CA2678525A1 (en) 2008-10-02
ZA200907539B (en) 2011-04-28
EP1974735A1 (en) 2008-10-01
BRPI0809630A2 (pt) 2014-09-23
RU2009139657A (ru) 2011-05-10
CL2008000927A1 (es) 2009-03-27
AU2008231930A1 (en) 2008-10-02
EP2142198B1 (en) 2014-01-22
MX2009009670A (es) 2009-12-14

Similar Documents

Publication Publication Date Title
MX2009009670A (es) Reduccion de riesgo de diarrea.
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
PH12014501749B1 (en) A nutritional composition comprising probiotics and improving sleep patterns
UA97663C2 (ru) Применение bifidobacterium lactis cncm i-3446 для улучшения кишечной микробиоты у детей, родившихся путем кесарева сечения
MY158816A (en) Probiotics for reduction of risk of obesity
PH12017500874A1 (en) Human milk oligosaccharides for modulating inflammation
MY166945A (en) Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
IN2012DN00878A (ru)
UA100985C2 (ru) Композиция для питания с нежизнеспособной бифидобактерией и неусваиваемым олигосахаридом
NZ601141A (en) Nutritional formulas containing synbiotics
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
MY145116A (en) Infant or follow-on formula
MX339112B (es) Formula alimenticia para bebes y niños pequeños que comprenden probioticos para bebes y niños pequeños.
MY177636A (en) Use of lactic acid bacteria to treat or prevent eczema
MY174541A (en) Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MX356184B (es) Fórmulación pediátrica sintética que comprende un probiótico.
NZ613180A (en) Methods of using human milk oligosaccharides for improving airway respiratory health
MY197622A (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
MX2014000895A (es) Galacto-oligosacaridos para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
TH144912A (th) การลดความเสี่ยงในการเป็นโรคท้องเสีย
TH126344B (th) องค์ประกอบทางโภชนาการซึ่งประกอบรวมด้วยโปรไบโอติก และปรับปรุงรูปแบบการนอนหลับ